Brief: Merck Held Talks To Buy Swiss Biotech Moonlake For More Than $3 Bln- FT
02/06/2025 21:52
June 2 (Reuters) - MERCK HELD TALKS TO BUY SWISS BIOTECH MOONLAKE FOR MORE THAN $3BN- FT Source text: [https://on.ft.com/43pXSbT] Further company coverage: MRK.N ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial